The U.S. Securities and Exchange Commission on Thursday said it settled claims against three Morgan Stanley entities accused of misleading investors in a pair of residential mortgage-backed securitizations that were the last subprime deals the firms underwrote, sponsored and sold.
General Motors Co. expects to set aside at least $400 million for its compensation fund for death and injury victims of accidents arising from faulty ignition switches, the automaker disclosed in its second-quarter earnings report Thursday.
Barclays PLC asked a state judge Thursday to toss New York Attorney General Eric T. Schneiderman's claims the firm tried to increase the market share of its dark pool by lying to clients and investors, saying not only did it not commit fraud but that the attorney general has no regulatory authority to bring his claims.
Novartis AG unit Sandoz Inc. announced Thursday that the U.S. Food and Drug Administration is reviewing its request to market a biosimilar version of Amgen Inc.'s Neupogen, a milestone that marks the first publicly disclosed application along an Affordable Care Act approval pathway.
Bank of America Corp. agreed to a more than $16.5 million settlement with the U.S. Department of the Treasury's sanctions enforcement unit over allegations that the bank processed around 200 transactions for known drug traffickers subject to U.S. sanctions, the Treasury said Thursday.
The U.S. Securities and Exchange Commission has denied an award to a would-be tipster who sought to collect portion of the $18 million paid to the agency after its landmark enforcement action last year against Harbinger Capital Partners LLC and its chief executive Philip Falcone, according to newly released documents.